Spruce Biosciences   Report issue

For profit Phase 2
Founded: San Francisco CA United States (2014)

Organization Overview

First Clinical Trial
2017
NCT03257462
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Spruce Biosciences